Autopsy report · NCT03585101

A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk

“Funding no longer available”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of California, Los Angeles

Sponsor type

University, hospital or other

Conditions

Hepatitis C

Interventions

Elbasvir/grazoprevir

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Buddhist Awareness Training Program and Qigong Psychosocial Interventions for People With Insomnia
  “Funding not available” (92% match in meaning)
• Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
  “Funding has become unavailable” (91% match in meaning)
• Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer
  “Funding was not available” (90% match in meaning)
• Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
  “funding became unavailable” (90% match in meaning)
• Digital Art Therapy for Young Cancer Survivors
  “Funding unavailable” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.